Mitchell Kaye, MD
Urology · Phoenix, AZNPI 1760487367
Payments from drug & device makers
Across 75 payments — averaging $124.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$4K
- Arthrex$2K
- Neotract Inc.$957
- Coloplast$695
- Valencia Technologies Corporation$625
- Olympus America Inc.$303
- plus $1K from 16 others
What the payments were for
- Speaking & faculty fees$3,32036%
- Travel & lodging$1,62517%
- Food & beverage$2,44826%
- Education$1,91121%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 7 | $3,703 |
| Arthrex | 4 | $1,927 |
| Neotract Inc. | 15 | $957 |
| Coloplast | 13 | $695 |
| Valencia Technologies Corporation | 2 | $625 |
| Olympus America Inc. | 3 | $303 |
| Progenics Pharmaceuticals, Inc. | 3 | $166 |
| Procept Biorobotics Corporation | 1 | $149 |
| Pfizer | 3 | $126 |
| Intuitive Surgical | 1 | $124 |
| Myriad Genetic Laboratories, Inc. | 5 | $103 |
| Medtronic | 1 | $99 |
| Axonics, Inc. | 4 | $83 |
| Blue Earth Diagnostics | 3 | $69 |
| Urogen Pharma, Inc. | 3 | $53 |
| Tolmar, Inc. | 1 | $23 |
| Endo USA, Inc. | 1 | $18 |
| Tolmar Pharmaceuticals, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Accord Healthcare, Inc. | 1 | $17 |
| Urovant Sciences Inc | 1 | $15 |
| Covidien LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift System$3,320
- UroLift$1,105
- eCoin Device Kit$621
- Porges Coloplast$336
- AquaBeam Robotic System$149
- Bovie$148
- Da Vinci Surgical System$124
- PYLARIFY$122
- Orchestra$118
How this compares
$9,303 in reported general payments places this provider in the 70th percentile of 269 urology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 101 | $97,552 |
| Tamsulosin Hcl | 435 | $6,493 |
| Methenamine Hippurate | 76 | $5,721 |
| Tolterodine Tartrate ErTolterodine Tartrate | 85 | $4,056 |
| Finasteride | 208 | $3,148 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 127 | $2,128 |
| Sodium ChlorideSodium Chloride Irrig Solution | 15 | $1,902 |
| Testosterone | 22 | $1,855 |
| Potassium Citrate ErPotassium Citrate | 17 | $1,181 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 59 | $839 |
| Dutasteride | 14 | $804 |
| Bicalutamide | 25 | $532 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 27 | $409 |
| Oxybutynin Chloride ErOxybutynin Chloride | 30 | $405 |
| Solifenacin Succinate | 14 | $395 |
Paid to pharmacies, not to this prescriber.
Other urology in Phoenix
- Mitchell HumphreysPhoenix$1.1M
- Donald LammPhoenix$403K
- Jack AndrewsPhoenix$331K
- Daniel JaffeePhoenix$280K
- Karen SternPhoenix$147K
- Christopher WolterPhoenix$114K
- Ali BorhanPhoenix$42K
- Premal DesaiPhoenix$33K
- Sanjay RamakumarPhoenix$19K
- Yoon HongPhoenix$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.